Analogic (ALOG) Reports Q4 Adj-EPS of $0.11, Misses by 15c
More News related to ALOG
- BK Medical Announces New Three-Year Agreement with MedAssets
- Analogic Corporation Announces Timing for First Quarter Fiscal 2010 Earnings Conference Call
- Analogic Corporation Receives U.S. Government Certification for eXaminer XLB Explosives Detection System
- Analogic Corporation to Webcast Investor Day
- Analogic (ALOG) Maintains $0.10 Qtr. Dividend, Yielding 1.11%
More News related to Earnings
- Human Genome (HGSI) Raises Money As It Gears Up for Benlysta Approval
- Human Genome Sciences (HGSI) To Offer Up to 12.5M Shares
- ZymoGenetics (ZGEN) Higher Ahead of Presentation
- Somaxon Pharmaceuticals (SOMX) Surges Ahead of FDA Action Date
- BioMarin Pharmaceutical (BMRN) Announces FDA Grants Orphan Drug Designation for 3,4-DAP
Analogic Corporation (NYSE: ALOG) reports Q4 EPS of $0.11, ex-items, 15 cents lower than the analyst estimate of $0.26. Revenue for the quarter was $98.3 million, which compares to the estimate of $94.52 million.
Related Categories
EarningsHot List
Stocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
